Autolus Therapeutics PLC (AUTL)
4.795
-0.04
(-0.93%)
USD |
NASDAQ |
Apr 18, 16:00
4.795
0.00 (0.00%)
After-Hours: 20:00
Autolus Therapeutics Shareholders Equity (Quarterly): 111.47M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 111.47M |
| September 30, 2023 | 180.52M |
| June 30, 2023 | 229.34M |
| March 31, 2023 | 266.92M |
| December 31, 2022 | 298.67M |
| September 30, 2022 | 161.15M |
| June 30, 2022 | 214.52M |
| March 31, 2022 | 271.14M |
| December 31, 2021 | 313.32M |
| September 30, 2021 | 244.73M |
| June 30, 2021 | 283.68M |
| Date | Value |
|---|---|
| March 31, 2021 | 299.57M |
| December 31, 2020 | 210.03M |
| September 30, 2020 | 236.81M |
| June 30, 2020 | 258.95M |
| March 31, 2020 | 287.48M |
| December 31, 2019 | 254.84M |
| September 30, 2019 | 269.64M |
| June 30, 2019 | 298.22M |
| March 31, 2019 | 217.88M |
| March 31, 2018 | 127.10M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
111.47M
Minimum
Dec 2023
313.32M
Maximum
Dec 2021
246.90M
Average
258.95M
Median
Jun 2020
Shareholders Equity (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 39.51M |
| NuCana PLC | 18.96M |
| TC BioPharm (Holdings) PLC | 3.421M |
| Biodexa Pharmaceuticals Plc | 6.684M |
| Mereo BioPharma Group PLC | 50.54M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 375.38M |
| Total Liabilities (Quarterly) | 263.91M |